Guidelines for Appropriate and Safe Transfusion
Article information
J Korean Med Assoc. 2006;49(5):391-401
Publication date (electronic) : 2006 May 31
doi :
https://doi.org/10.5124/jkma.2006.49.5.391
Abstract
Transfusion can cause transfusion-transmitted diseases and various transfusion reactions. Recent improvements in the safety of blood supply and the increasing costs associated with transfusion therapies have led to a re-evaluation of the clinical practices of blood transfusion and blood conservation, which need practical guidelines for the use of constituent parts of blood. The traditional threshold of the hemoglobin concentration at 10g/dL for RBC transfusion has moved down to 7g/dL, and that of the platelet count at 20×109/L for platelet transfusion can also be lowered to 5×109/L. To improve the transfusion practice, as recommended by the guidelines, a prospective audit allied to educational programs can be effective in modifying the clinicians' practices of requesting transfusions.
Keywords: Blood; Transfusion; Guidelines
References
1. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G. The Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care. N Engl J Med 1999. 340409–417.
2. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Califf RM, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004. 2921555–1562.
3. Tinmouth A, Macdougall L, Fergusson D, Amin M, Graham ID, Wilson K. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices. Arch Intern Med 2005. 165845–852.
5. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Williamson LM, et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001. 11324–31.
6. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovahs Witnesses. Transfusion 1994. 34396–401.
7. Weiskopf RB. Do we know when to transfuse red cells to treat acute anemia? Transfusion 1998. 38517–521.
8. American Association of Blood Banks (AABB). Standards for Blood Banks and Transfusion Services 2002. 21st edth ed. Bethesda: American Association of Blood Banks;
9. Garrioch M, Sandbach J, Pirie E, Morrison A, Todd A, Green R. Reducing red cell transfusion by audit, education and a new guideline in a large teaching hospital. Transfus Med 2004. 1425–31.
10. Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991. 3381223–1226.
11. Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Link H, et al. Safety and cost effectiveness of a 10×10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20×10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998. 913601–3606.
12. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Sirchia G, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997. 3371870–1875.
13. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Wagnon AH, et al. American Society of Clinical Oncology. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001. 191519–1538.
14. British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003. 12210–23.
15. American Association of Blood Banks (AABB). In : Brecher ME, ed. Blood transfusion practice. Technical Manual 2005. 15th edth ed. Bethesda: American Association of Blood Banks; 488–492.
16. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Williamson LM, et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004. 12611–28.
17. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004. 126139–152.
18. Holland LL, Foster TM, Marlar RA, Brooks JP. Fresh frozen plasma is ineffective for correcting minimally elevated international normalized ratios. Transfusion 2005. 451234–1235.
19. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Busch MP, et al. National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004. 351760–768.
20. Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Schwarz V, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997. 63964–967.
21. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts-blood conservation. N Engl J Med 1999. 340525–533.
22. Walsh TS, Garrioch M, Maciver C, Lee RJ, MacKirdy F, Wallis C, et al. Audit of Transfusion in Intensive Care in Scotland Study Group. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 2004. 441405–1411.
Article information Continued
Copyright © 2006 Korean Medical Association
